Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilocarpine After Combined Cataract/Trabectome Surgery
NCT04005079Phase 3Withdrawn
- Sponsor
- Montefiore Medical Center
- Start
- Jun 2019
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pilocarpine in open-angle glaucoma (OAG), ocular hypertension, sponsored by Montefiore Medical Center. Planned start Jun 2019; status: withdrawn.
02
Drugs
pilocarpine
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT04005079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04005079.